A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : sTRAIL

Search Conditions:
Search Keyword : sTRAIL
Search Method : Exact match.
Research Area:

Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: sTRAIL
Appearance Frequency: 113 time(s)
Long forms: 15

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
soluble TRAIL
(58 times)
(17 times)
TRAIL (32 times)
TNF (8 times)
MSCs (5 times)
2000 The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation.
soluble tumor necrosis factor-related apoptosis-inducing ligand
(26 times)
(4 times)
AAV (2 times)
ELISA (2 times)
hAT-MSC (2 times)
2005 [Soluble tumor necrosis factor related apoptosis inducing ligand (sTRAIL) and clinical outcome of HBV infection in human].
soluble TNF-related apoptosis-inducing ligand
(13 times)
(1 time)
TNF (3 times)
IL-6 (2 times)
ADPKD (1 time)
1998 Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity.
serum-soluble TRAIL
(3 times)
(1 time)
TRAIL (3 times)
CML (1 time)
DM (1 time)
2007 Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.
soluble forms of TRAIL
(2 times)
(1 time)
EMPs (1 time)
HUVECs (1 time)
TRAIL (1 time)
2009 TRAIL/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation.
soluble tumor necrosis factor-related ligand
(2 times)
Allergy and Immunology
(1 time)
PEG-IFN (1 time)
2006 Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis C.
secreted form of TRAIL
(1 time)
Genetics, Medical
(1 time)
rAAV (1 time)
TRAIL (1 time)
2005 Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
serum soluble apoptosis marker
(1 time)
(1 time)
TRAIL (1 time)
2013 [The relationship between serum soluble apoptosis marker (sTRAIL) concentration and nutritional parameters in hemodialyzed patients].
soluble bioactive form of TRAIL
(1 time)
(1 time)
CML (1 time)
IFN-alpha (1 time)
PBMCs (1 time)
2004 IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells.
10  soluble extracellular domain of proapoptotic TNF-related apoptosis-inducing ligand
(1 time)
(1 time)
BPL (1 time)
PK (1 time)
TRAIL-R (1 time)
2015 Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia.
11  soluble extracellular domain of TRAIL
(1 time)
Allergy and Immunology
(1 time)
B-ALL (1 time)
B-CLL (1 time)
scFv (1 time)
2007 Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein.
12  Soluble recombinant derivatives of TRAIL
(1 time)
Molecular Biology
(1 time)
TNF (1 time)
TRAIL (1 time)
2001 Differential activation of TRAIL-R1 and -2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative.
13  Soluble Tumour Necrosis Factor Ligand inducing Apoptosis
(1 time)
(1 time)
OPG (1 time)
TRAIL (1 time)
2020 Changes in the Concentration of Markers Participating in the Regulation of the Apoptosis Receptor Pathway Involving Soluble Tumour Necrosis Factor Ligand inducing Apoptosis (sTRAIL) and Osteoprotegerin (OPG) in the Serum of Women with Ovarian Cancer-Participation in Pathogenesis or a Possible Clinical Use?
14  soluble variant of TRAIL
(1 time)
(1 time)
BF (1 time)
ES (1 time)
GD2 tCAR (1 time)
2021 Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma.
15  susceptible to TRAIL ligand
(1 time)
Cell Biology
(1 time)
MDR (1 time)
2015 Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL.